Clinical evaluation of autoantibodies to a novel PM/Scl peptide antigen
Anti-PM/Scl antibodies represent a specific serological marker for a subset of patients with scleroderma (Scl) and polymyositis (PM), and especially with the PM/Scl overlap syndrome (PM/Scl). Anti-PM/Scl reactivity is found in 24% of PM/Scl patients and is found in 3–10% of Scl and PM patients. The...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2005
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1174964/ |